Dr. Ivan Babic has extensive experience in brain tumor research, and is the Assistant Professor within the Department of Translational Neurosciences and Neurotherapeutics at the John Wayne Cancer Institute. He is also a research scientist with the Pacific Neuroscience Institute’s precision medicine research team. Dr. Babic received his Doctorate in Biochemistry – Cancer Biology from the University of Calgary in Canada, and his fellowship training was in cancer metabolism at the University of California Los Angeles (UCLA) at the David Geffen School of Medicine.
Dr. Babic’s research interests are to understand how aberrant cell signaling alters gene expression to reprogram tumor metabolism. The long-term goal of the research is to identify metabolic vulnerabilities that may be exploited therapeutically. He has published several high impact manuscripts in the field of cancer cell metabolism, and his focused research efforts have already formed the foundation for the development of several novel “targeted therapies” – antibodies and small molecules (drugs) directed to unique properties of cancer cells – for the safe and effective treatment of brain tumors.